Absence of Oxalobacter formigenes in cystic fibrosis patients: A risk factor for hyperoxaluria

Lancet

Volumn 352, Issue 9133, 1998, Pages 1026-1029

  Sidhu, Harmeet ^a   Hoppe, Bernd ^b   Hesse, Albrecht ^f   Tenbrock, Klaus ^d   Brömme, Sabine ^c   Rietschel, Ernst ^d   Peck, Ammon B ^e  

^a Division of Oxalate Research   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; OXALIC ACID;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; CHILD; COLONY FORMING UNIT; CONTROLLED STUDY; CYSTIC FIBROSIS; FECES CULTURE; FEMALE; HUMAN; HYPEROXALURIA; INTESTINE ABSORPTION; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STONE FORMATION; UROLITHIASIS;

EID: 0032569512     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)03038-4     Document Type: Article

References (28)

1. 1 Strandvik B, Hjelte L. Nephrolithiasis in cystic fibrosis. Acta Paediatr 1993; 82: 306-07.
2. 2 Matthews LA, Doershuk CF, Stern RC, Resnick MI. Urolithiasis in cystic fibrosis. J Urol 1996; 155: 1563-64.
3. 3 Katz S, Krueger LJ, Falkner B. Microscopic nephrocalcinosis in cystic fibrosis. N Engl J Med 1988; 319: 263-66.
4. 4 Joseph DB. Report of the Annual Meeting of the American Academy of Pediatrics. Pediatrics 1996; 98: 108-14.
5. 5 Parries G, Whol ME, Khaw KT, Lapey A, Bauer SB. Urolithiasis: a late complication of CF. Dallas: Cystic Fibrosis Conference, 1995: 393.
6. 6 Böhles H, Michalk D. Is there a risk for kidney stone formation in cystic fibrosis? Helv Paediatr Acta 1982; 37: 267-72.
7. 7 Hoppe B, Hesse A, Bromme S, Rietschel E, Michalk D. Urinary excretion parameters in patients with cystic fibrosis: risk of urolithiasis? Pediatr Nephrol 1998; 12: 275-79.
8. 8 Dobbins JW, Blinder HJ. Importance of the colon in enteric hyperoxaluria. N Engl J Med 1977; 269: 298-301.
9. 9 Stauffer JQ, Humphreys MH. Hyperoxaluria with intestinal disease. N Engl J Med 1972; 287: 412.
10. 10 Bentur L, Kerem E, Couper R, et al. Renal calcium handling in cystic fibrosis: lack of evidence for a primary renal defect. J Pediatr 1990; 116: 556-60.
11. 11 Seftel A, Resnick MI. Metabolic evaluation of urolithiasis. Urol Clin North Am 1990; 17: 159-69.
12. 12 Binder HJ. Intestinal oxalate absoption. Gastroenterology 1974; 67: 441-46.
13. 13 Modigliani R, Labayle D, Aymed C, Denvil R. Evidence for excessive absorption of oxalate by colon in enteric hyperoxaluria. Scand J Gastroenterol 1978; 12: 187-92.
14. 14 Allison MJ, Cook HM, Milne DB, Gallagher S, Clayman RV. Oxalate degradation by gastrointestinal bacteria from humans. J Nutr 1986; 116: 455-60.
15. 15 Goldkin L, Cave DR, Jaffin B, Bliss CM, Allison MJ. Bacterial oxalate metabolism in the human colon: a possible factor in enteric hyperoxaluria. Gastroenterology 1986; 90: 1431-32.
16. 16 Goldkin L, Cave DR, Jaffin B, Robinson W, Bliss SM. A new factor in enteric hyperoxaluria: Oxalobacter formigenes. Am J Gastroenterol 1985; 80: 860.
17. 17 Allison MJ, Dawson KA, Mayberry WR, Foss JG. Oxalobacter formigenes gen nov, sp nov: oxalate degrading bacteria that inhabit the gastrointestinal tract. Arch Microbiol 1985; 141: 1-7.
18. 18 Hatch M, Freel RW. Oxalate transport across intestinal and renal epithelia. In: Khan S, ed. Calcium oxalate in biological systems. Boca Raton, Florida: CRC Press, 1996: 217-38.
19. 19 Sidhu H, Yenatska L, Ogden SD, Allison MJ, Peck AB. Natural colonization of children in the Ukraine with the intestinal bacterium, Oxalobacter formigenes, using a PCR-based detection system. Mol Diagn 1997; 2: 89-97.
20. 20 Argenzio RA, Liacos JA, Allison MJ. Intestinal oxalate-degrading bacterial reduce oxalate absorption and toxicity in guinea pigs. J Nutr 1988; 118: 787-92.
21. 21 Han J, Zhang X, Li J, Zhang Y. The relationship of Oxalobacter formigenes and calcium oxalate calculi. J Tongji Med Univ 1985; 15: 249-52.
22. 22 Hoppe B, Jahnen A, Bach D, Hesse A. Urinary calcium-oxalate saturation in healthy infants and children. J Urol 1997; 158: 557-59.
23. 23 Hesse A, Classen A, Knoll M, Timmermann F, Vahlensieck W. Dependence of urine composition on the age and sex of healthy subjects. Clin Chim Acta 1986; 160: 79-86.
24. 24 Werness PG, Brown CM, Smith LH, Finlayson B. EQUIL2: a basic computer program for the calculation of urinary saturation. J Urol 1985; 134: 1242-44.
25. 25 Kleinschmidt K, Mahlmann A, Hautmann R. Anaerobic oxalate degrading bacteria in the gut decrease fecal and urinary oxalate concentrations in stone formers. In: Ryall R, Bais R, Marshall VR, Rofe AM, Smith LH, Walker VR, eds. Urolithiasis 2. New York: Plenum, 1993: 439-41.
26. 26 Crawford I, Maloney PC, Zeitlin PL, et al. Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc Natl Acad Sci USA 1991; 88: 9262-66.
27. 27 Robson AM, Tateishi S, Ingelfinger JR, Strominger DB, Klahar S. Renal function in patients with cystic fibrosis. J Pediatr 1971; 79: 42-50.
28. 28 Doane LT, Liebman M, Caldwell DR. Microbial oxalate degradation: effect on oxalate and calcium balance in humans. Nutr Res 1989; 9: 957-64.